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ABSTRACT: A mild and rapid method for the iodination of arenes that utilizes
silver(I) triﬂimide as a catalyst for activation of N-iodosuccinimide has been
developed. The transformation was found to be general for a wide range of
anisole, aniline, acetanilide, and phenol derivatives and allowed the late-stage
iodination of biologically active compounds such as PIMBA, a SPECT imaging
agent of breast cancer, and (−)-IBZM, a dopamine D2 receptor antagonist. The
method was also modiﬁed for the radioiodination of arenes using a one-pot
procedure involving the in situ generation of [125I]-N-iodosuccinimide followed by the silver(I)-catalyzed iodination.
■ INTRODUCTION
Aryl iodides are highly important building blocks widely used in
total synthesis, medicinal chemistry, and material science. This
general versatility is due to the higher reactivity of the C−I
bond compared to the corresponding aryl bromide or chloride,
allowing their use in highly eﬀective metal-catalyzed cross-
coupling reactions and nucleophilic aromatic substitution
reactions and for the generation of free-radical intermedi-
ates.1−3 Aryl iodides are also found as components in a number
of medicinally important compounds such as 8-iodoharmaline
(1), a potent monoamine oxidase inhibitor,4 and 1-(2,5-
dimethoxy-4-iodophenyl)-2-aminopropane (DOI) (2), a 5-
HT2A receptor agonist and inhibitor of tumor necrosis factor-α-
induced inﬂammation (Figure 1).5 When used in combination
with single photon emission computed tomography (SPECT)
imaging, radioiodinated aryl compounds also have signiﬁcant
impact on healthcare, ﬁnding application in clinical diagnosis,
drug development, and biomedical research.6 For example,
[123I]-PIMBA (3)7 and (−)-[123I]-IBZM (4)8 are SPECT
imaging agents of human breast cancer and the human D2
receptor, respectively, while the iodinated benzoxazole, [125I]-
IBOX (5), has been used to image amyloid plaques in the brain
(Figure 1).9
Due to the importance of aryl iodides, there has been much
focus on the development of general methods for their
synthesis that overcome the harsh reagents and conditions
associated with more traditional approaches such as electro-
philic aromatic substitution with iodine and the Sandmeyer
reaction.10,11 A recent advance has been the discovery of
copper- or nickel-catalyzed Finkelstein reaction of aryl
bromides (Scheme 1a).12−14 Other iodide exchange reactions
using leaving groups such as triﬂates and boronic acids have
also been reported.15,16 More direct methods that negate the
need for installation of a leaving group and which can be
performed at lower temperatures have also been developed.17,18
A common approach is the activation of electrophilic iodine-
Received: December 4, 2015
Published: January 21, 2016
Figure 1. Structures of aryl iodide containing inhibitors and SPECT
imaging agents.
Scheme 1. Metal-Catalyzed Methods for Iodination of
Arenes
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containing reagents such as N-iodosuccinimide (NIS).19 For
example, Olah and co-workers used a combination of boron
triﬂuoride and water for the Brønsted acid activation of NIS
and the iodination of electron-deﬁcient arenes,20 while the
groups of Romo and Frontier used indium(III) and gold(I)
complexes, respectively, for the Lewis acid activation of NIS
and the iodination of electron-rich arenes (Scheme 1b).21
We have a longstanding interest in rapid and eﬃcient
methods for the iodination and radioiodination of arenes that
can facilitate the development of novel SPECT imaging
agents.22 To this end, we recently reported an iron(III)-
catalyzed method for NIS activation and the subsequent
iodination of activated arenes (Scheme 1b).23 While this
method could be accelerated using a triﬂimide based ionic
liquid, leading to faster reactions at lower temperatures
compared to other metal-catalyzed methods, some limitations
were observed. In particular, we found that reaction of very
active substrates such as phenols with the highly charged, hard
iron(III) Lewis acid led to the formation of bis-iodinated
products, thereby restricting the yield of the major mono-
iodinated compounds. As SPECT imaging agents often contain
electron-rich aryl moieties including phenols (see Figure 1), we
decided to investigate softer metals that would tune the
activation of NIS leading to cleaner reactions of highly activated
aryl compounds. Herein, we report the development of a
silver(I) triﬂimide catalyzed iodination method that can be used
for a wide range of substrates. As well as demonstrating the
application of this procedure for the iodination of medicinally
important compounds, it is also shown that this reaction can be
modiﬁed for the radioiodination of activated arenes.
■ RESULTS AND DISCUSSION
Having previously shown that iron(III) was highly eﬀective for
activation of NIS (Table 1, entry 2),23 initial studies focused on
screening softer, less charged Lewis acids that could result in
cleaner iodination reactions. Both copper(I) chloride and
iron(II) chloride showed little activity for the iodination of
anisole (6a) (entries 3 and 4), and while a palladium(II)
complex eventually gave good conversion, the rate of the
reaction was relatively slow (entry 5). A similarly slow reaction
but good overall conversion was observed when silver(I)
hexaﬂuoroantimonate was used (entry 6). Interestingly, the use
of this silver(I) salt showed very clean conversion, and so other
more active silver(I) salts were investigated. In our previous
studies, we found that the Lewis acidic nature of a metal could
be enhanced by forming the triﬂimide salt.23 The combination
of the highly delocalized nature of the triﬂimide anion and its
steric hindrance results in signiﬁcant positive charge density on
the metal cation leading to powerful Lewis acidic character.24
Using this reasoning, silver(I) triﬂimide was next attempted,
and this showed complete conversion after 1.5 h (entry 7).
Further investigation revealed an optimal catalyst loading of 7.5
mol % that gave, after 1.5 h, an 86% isolated yield of
iodoanisole as a 93:7 mixture of para- and ortho-isomers,
respectively.
To further evaluate the suitability of silver(I) triﬂimide as a
catalyst for NIS-mediated arene iodination reactions, the
relative rate of reaction of anisole (6a) was compared with
other metal-based Lewis acids known to perform this
transformation (Figure 2).21,23 At 36 °C and using a catalyst
loading of 7.5 mol %, silver(I) triﬂimide was found to be
signiﬁcantly faster than both indium(III) triﬂate and the gold(I)
triﬂimide complex. For comparison, data using iron(III)
chloride under the optimized conditions of 5 mol % catalyst
loading and a reaction temperature of 20 °C is also presented in
Figure 2. Although the optimized conditions for the silver(I)
triﬂimide procedure requires a slightly higher catalyst loading
and reaction temperature, the relative rate of reaction with the
softer Lewis acid compares favorably to the iron(III) chloride
method.
The scope of iodination using silver(I) triﬂimide was then
explored using a range of anisole, aniline, and acetanilide
derivatives (Scheme 2). For all substrates investigated, the
silver(I)-catalyzed iodination was found to be compatible with a
wide range of functional groups, generating the products
cleanly and eﬃciently.25 Analysis of crude reaction mixtures by
1H NMR spectroscopy showed the presence in all cases of only
a single monoiodinated regioisomer. Substrates such as 7h−k
with strongly deactivating groups also showed high reactivity,
giving the products in nearly quantitative yields after only a few
hours of reaction time. The ability to use this procedure for
multigram synthesis of iodinated arenes was investigated using
Table 1. Activity Screen of Metal Catalysts for Iodination of
Anisole (6a)a,b
entry catalyst conv at 1.5 h (%) conv at 21 h (%)
1 <2 11
2 FeCl3 100
3 CuCl <2 24
4 FeCl2 <2 24
5 Pd(MeCN)2Cl2 7 96
6 AgSbF6 12 74
7 AgNTf2 100
aConversions were measured using 1H NMR spectroscopy. bFor all
reactions, a ratio of >9:1 was observed in favor of the para-isomer.
Figure 2. Iodination of anisole (6a) with various Lewis acids.
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4-nitroaniline 6j. It was found that on scale up, the catalyst
loading of the silver(I) triﬂimide could be lowered to 2 mol %.
This lower catalyst loading in combination with the standard
reaction conditions (40 °C, 1.5 h) gave 7j on a gram scale in
90% yield. Further exploration of the scope of this procedure
with other activated substrates such as methoxynaphthalenes 6n
and 6o, 2,3-dihydrobenzofuran (6p), and pyrrole 6q similarly
gave iodinated products 7n−q in high yields.
The ability of the silver(I) triﬂimide procedure for iodination
of highly activated phenol substrates was next investigated
(Scheme 3). For the majority of compounds, it was found that
initial cooling of the reaction mixture in combination with the
soft silver(I) Lewis acid led to the suppression of over-
iodination and the rapid and eﬃcient formation of the
monoiodinated compounds.26 Again, inspection of the reaction
mixtures by 1H NMR spectroscopy revealed the presence of
only a single iodinated regioisomer. It should be noted that
even highly active diol 9c gave only a single product, 3-
iodoacetophenone 10c, in 74% yield.
The silver(I)-catalyzed method was then extended for the
synthesis of medicinally important iodine-containing com-
pounds (Scheme 4). PIMBA (3),7 the SPECT-imaging agent of
human breast cancer, was prepared in two steps from amide 11.
As NIS is known to react with nucleophilic groups,21a,23 the
amine functionality of 11 was initially protected as the
tetraﬂuoroborate salt. Iodination with silver(I) triﬂimide then
gave 3 in 94% yield over the two steps. In a similar fashion,
(−)-IBZM (4),8 the SPECT imaging agent of the dopamine D2
receptor was prepared in 71% yield from 12. When iron(III)
was used to activate NIS for the synthesis of (−)-IBZM (4) in
our previous study, the procedure was complicated by the
formation of the bis-iodinated product, resulting in a 47% yield
of 4.23 Here, the use of the softer silver(I) catalyst
circumvented this issue with a cleaner iodination reaction and
a higher yield of the target compound. The selective iodination
of a bis-arylated compound, 13 was also examined. Reaction of
13 with NIS and silver(I) triﬂimide was complete after 1 h at 20
°C and gave iodinated compound 14 as a single product in 94%
yield. In this case, only the para-position of the more activated
aryl ring was iodinated. The carboxylic acid of compound 14 is
a nanomolar inhibitor of the kinase MEK1 and a metabolite of
PD0325901, a compound active against malignant tumors.27
Having achieved the main objective of this research program,
the identiﬁcation of a soft metal based Lewis acid for the rapid,
general, and selective iodination of a range of arenes, the ﬁnal
goal was the modiﬁcation of this procedure for radioiodination.
Radiolabeled iodide is produced in the form of the sodium salt,
and it was proposed that this could be used as part of a one-pot
radioiodination process by reaction with N-chlorosuccinimide
(NCS) to produce radiolabeled NIS,28,29 followed by the
silver(I) triﬂimide catalyzed reaction with arenes. In a
preliminary study, it has been shown that a one-pot procedure
can be used from NCS to give radioiodinated compounds in
good radiochemical yields (RCY) (Scheme 5).30 Due to the
high sensitivity of SPECT, [123I]- and [125I]-imaging agents are
generally prepared in low micromole quantities and so during
this part of the project, the scale of the iodination procedure
was adjusted to mimic these conditions (3 micromole of
substrate). [125I]-NIS was initially prepared from NCS and 5.3
MBq of [125I]-NaI, and this was used for the radioiodination of
1-methoxynaphthalene (6n). With [125I]-NIS as the limiting
reagent in these reactions, optimization studies found that 0.6
equiv of silver(I) triﬂimide gave the best conversion of 6n.
Analysis using radio-HPLC showed a 61% radiochemical yield
of [125I]-7n after a reaction time of 1.1 h. 2-Hydroxy-6-
methoxybenzaldehyde (9d), a mimic of the aryl component of
(−)-IBZM (4) was next investigated. Using [125I]-NIS prepared
from 2.7 MBq of [125I]-NaI and then 0.3 equiv of silver(I)
triﬂimide gave [125I]-10d after 0.3 h in 64% radiochemical yield.
Some side-products were observed by radio-HPLC during the
radioiodination of both compounds, but these were generally in
small amounts and easily separable from the major product.
Scheme 2. Scope of Silver(I) Triﬂimide Catalyzed Iodination
aGram-scale synthesis using a catalyst loading of 2 mol % gave 7j in
90% yield.
Scheme 3. Silver(I) Triﬂimide Catalyzed Iodination of
Phenols
The Journal of Organic Chemistry Featured Article
DOI: 10.1021/acs.joc.5b02761
J. Org. Chem. 2016, 81, 772−780
774
While these results are preliminary, they show that this one-pot
approach can be used to access radioiodinated compounds.
■ CONCLUSIONS
In summary, a method for the iodination of arenes via the
activation of NIS using silver(I) triﬂimide has been developed.
The combination of using a soft, low-charged silver(I) Lewis
acid which is still relatively active due to the noncomplexing
triﬂimide counterion led to the fast and eﬃcient iodination of a
wide range of arenes. This tuning of NIS activation using
silver(I) suppresses overiodination resulting in monoiodination
of highly activated substrates such as phenols. The utility of this
method has been demonstrated with the high yielding
regioselective synthesis of a range of medicinally important
imaging agents including phenol containing dopamine D2
SPECT tracer (−)-IBZM (4). The generality of this procedure
was further exempliﬁed by the one-pot, two-step synthesis of
[125I]-labeled compounds from NCS and [125I]-NaI. Further
studies to extend the scope and application of this method are
underway.
■ EXPERIMENTAL SECTION
All reagents and starting materials were obtained from commercial
sources and used as received. All dry solvents were puriﬁed using a
solvent puriﬁcation system. All reactions were performed open to air
unless otherwise mentioned. Brine refers to a saturated solution of
sodium chloride. Flash column chromatography was performed using
silica gel 60 (35−70 μm). Aluminum-backed plates precoated with
silica gel 60F254 were used for thin-layer chromatography and were
visualized with a UV lamp or by staining with potassium
permanganate. 1H NMR spectra were recorded on a NMR
spectrometer at either 400 or 500 MHz, and data are reported as
follows: chemical shift in ppm relative to tetramethylsilane as the
internal standard, multiplicity (s = singlet, d = doublet, t = triplet, q =
quartet, m = multiplet or overlap of nonequivalent resonances,
integration). 13C NMR spectra were recorded on a NMR spectrometer
at either 101 or 126 MHz, and data are reported as follows: chemical
shift in ppm relative to tetramethylsilane or the solvent as internal
standard (CDCl3, δ 77.0 ppm; CD3OD, δ 44.0 ppm; or DMSO-d6, δ
39.5 ppm), multiplicity with respect to hydrogen (deduced from
DEPT experiments, C, CH, CH2, or CH3). Infrared spectra were
recorded on a FTIR spectrometer; wavenumbers are indicated in
cm−1. Mass spectra were recorded using electron impact, chemical
ionization, or electrospray techniques. HRMS spectra were recorded
using a dual-focusing magnetic analyzer mass spectrometer. Melting
points are uncorrected. A solution of 74 MBq of [125I]-sodium iodide
in 3−4 μL of 0.01 M sodium hydroxide solution was azeotropically
dried under argon at 110 °C and reconstituted in anhydrous
acetonitrile. Analytical HPLC was performed using a 80 Å column
(150 × 4.6 mm) with 10 mm guard cartridge, UV 220 nm,
radiodetection and ﬂow of 1 mL/min. Analysis of the reaction mixture
(to assess radioiodide incorporation) used a gradient proﬁle of 0.1%
triﬂuoroacetic acid in water and 0.1% triﬂuoroacetic acid in
acetonitrile.
General Iodination Procedure. To a dry ﬂask (10 mL) ﬁtted
with a magnetic stirrer were added substrate (1.0 equiv), N-
iodosuccinimide (1.0−1.1 equiv), silver triﬂimide (7.5 mol %), and
dichloromethane (5−6 mL) under an atmosphere of air. The reaction
mixture was stirred in the dark at the required temperature. The
reaction progress was monitored by 1H NMR spectroscopy. The
reactions were stopped once all substrate was consumed. The reaction
mixture was diluted with dichloromethane (15 mL) and washed with
dilute aqueous solutions of sodium hydrogen carbonate (20 mL),
sodium thiosulfate (20 mL), and sodium chloride (20 mL). The
organic layer was dried over magnesium sulfate and ﬁltered. The
solvent was removed under reduced pressure, and the product was
puriﬁed by either column chromatography or by recrystallization.
Iodination of Highly Reactive/Phenol Substrates. To a dry
ﬂask ﬁtted with a magnetic stirrer were added substrate (1.0 equiv),
silver triﬂimide (7.5 mol %), and dichloromethane (4 mL) under an
atmosphere of air. The mixture was cooled to 0 °C and a solution of
N-iodosuccinimide (1.03 equiv) in dichloromethane (30 mL) was
added dropwise over 10 min. The reaction was then allowed to warm
up to room temperature, and if necessary heated to 36 °C in the dark.
The reaction progress was monitored by 1H NMR spectroscopy. The
reactions were stopped once all substrate was consumed and worked
up as described above.
Measurement of the Rate of Iodination of Anisole (6a).
Iodination of anisole (6a) was performed as described in the general
procedure above, using anisole (36 μL, 0.33 mmol), NIS (74 mg, 0.33
Scheme 4. Iodination of Medicinally Relevant Compounds
Scheme 5. One-Pot Radioiodination of 6n and 9d
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mmol) and either InOTf3 (13.9 mg, 7.5 mol %), Ph3PAuNTf2 (38 mg,
7.5 mol %), FeCl3 (2.7 mg, 5.0 mol %), or AgNTf2 (9.6 mg, 7.5 mol
%) at the temperatures shown in Figure 2. At the various time points
indicated in Figure 2, an aliquot (0.5 mL) was removed from the
reaction mixture. The sample was diluted with dichloromethane (3
mL) and washed with dilute aqueous solutions of sodium hydrogen
carbonate (5 mL), sodium thiosulfate (5 mL), and sodium chloride (5
mL). The dichloromethane layer was dried over magnesium sulfate
and ﬁltered. The solvent was removed under reduced pressure. The
resulting residue was dissolved in CDCl3 and the conversion of the
reaction was measured using 1H NMR spectroscopy. The calculation
was based on the integral values of iodoanisole (7a) signals at 7.52−
7.58 ppm compared to the starting material, anisole (6a) signals at
7.27−7.30 ppm.
4-Iodoanisole (7a).31 The reaction was performed as described in
the general procedure using anisole (6a) (53 μL, 0.49 mmol) and NIS
(110 mg, 0.49 mmol). The reaction mixture was heated to 36 °C for
1.5 h. Puriﬁcation by column chromatography eluting with 10% ethyl
acetate in petroleum ether gave the product as a white solid (98 mg,
86%; inseparable mixture of 4-iodoanisole (7a) and 2-iodoanisole
(8a), 93:7): mp 40−43 °C (lit.31 mp 43−45 °C). The spectroscopic
data are reported only for the major isomer 7a: 1H NMR (400 MHz,
CDCl3) δ 3.78 (s, 3H), 6.65−6.72 (m, 2H), 7.52−7.58 (m, 2H); 13C
NMR (101 MHz, CDCl3) δ 55.3 (CH3), 82.7 (C), 116.4 (2 × CH),
138.2 (2 × CH), 159.5 (C); MS (EI) m/z 234 (M+, 96), 219 (55), 191
(12), 84 (100), 49 (66).
2-Iodo-4-bromoanisole (7b).32 The reaction was performed as
described in the general procedure using 4-bromoanisole (6b) (56 μL,
0.44 mmol) and NIS (115 mg, 0.51 mmol). The reaction mixture was
heated to 40 °C for 7.3 h. Puriﬁcation by column chromatography
eluting with 15% ethyl acetate in petroleum ether gave 2-iodo-4-
bromoanisole (7b) (120 mg, 86%) as a light brown oil. The data were
consistent with the literature:32 1H NMR (500 MHz, CDCl3) δ 3.86
(s, 3H), 6.69 (d, J 8.7 Hz, 1H), 7.41 (dd, J 8.7, 2.4 Hz, 1H), 7.88 (d, J
2.4 Hz, 1H); 13C NMR (126 MHz, CDCl3) δ 56.6 (CH3), 86.7 (C),
112.0 (CH), 113.4 (C), 132.2 (CH), 141.2 (CH), 157.5 (C); MS (EI)
m/z 312 (M+, 100), 297 (44), 269 (13), 170 (26), 127 (6), 63 (19).
2-Methoxy-5-iodobenzaldehyde (7c).33 The reaction was per-
formed as described in the general procedure using 2-methoxybenzal-
dehyde (6c) (60.5 mg, 0.44 mmol) and NIS (110 mg, 0.49 mmol).
The reaction mixture was heated to 36 °C for 4 h. Recrystallization
from ethyl acetate and petroleum ether gave 2-methoxy-5-
iodobenzaldehyde (7c) (90 mg, 78%) as an oﬀ-white solid: mp
141−142 °C (lit.33 mp 140−141 °C); 1H NMR (500 MHz, CDCl3) δ
3.91 (s, 3H), 6.78 (d, J 8.8 Hz, 1H), 7.81 (dd, J 8.8, 2.4 Hz, 1H), 8.09
(d, J 2.4 Hz, 1H), 10.34 (s, 1H); 13C NMR (126 MHz, CDCl3) δ 55.9
(CH3), 83.0 (C), 114.1 (CH), 126.6 (C), 137.1 (CH), 144.1 (CH),
161.4 (C), 188.2 (CH); MS (ESI) m/z 284 (MNa+, 35), 236 (100),
218 (10).
2,4-Dimethoxy-5-iodobenzoic Acid (7d).34 The reaction was
performed as described in the general procedure using 2,4-
dimethoxybenzoic acid (6d) (80 mg, 0.44 mmol) and NIS (114 mg,
0.51 mmol). The reaction mixture was heated to 36 °C for 2 h.
Recrystallization from ethyl acetate and petroleum ether gave 2,4-
dimethoxy-5-iodobenzoic acid (7d) (91 mg, 67%) as a white solid: mp
204−205 °C (lit.34 mp 209.5−210.5 °C); 1H NMR (500 MHz,
DMSO-d6) δ 3.87 (s, 3H), 3.93 (s, 3H), 6.70 (s, 1H), 8.04 (s, 1H),
12.45 (br s, 1H); 13C NMR (126 MHz, DMSO-d6) δ 56.6 (CH3), 57.3
(CH3), 74.1 (C), 97.7 (CH), 114.9 (C), 141.6 (CH), 161.7 (C), 162.2
(C), 165.7 (C); MS (EI) m/z 308 (M+, 100), 291 (16), 261 (14), 233
(10), 152 (11), 95 (7).
2,4-Dimethoxy-5-iodobenzaldehyde (7e).35 The reaction was
performed as described in the general procedure using 2,4-
dimethoxybenzaldehyde (6e) (74 mg, 0.44 mmol) and NIS (115
mg, 0.51 mmol). The reaction mixture was heated to 40 °C for 1 h.
Recrystallization from ethyl acetate and petroleum ether gave 2,4-
dimethoxy-5-iodobenzaldehyde (7e) (127 mg, 98%) as a white solid:
mp 171−172 °C (lit.35 mp 170−172 °C); 1H NMR (400 MHz,
CDCl3) δ 3.95 (s, 3H), 3.97 (s, 3H), 6.40 (s, 1H), 8.22 (s, 1H), 10.20
(s, 1H); 13C NMR (126 MHz, CDCl3) δ 55.9 (CH3), 56.6 (CH3),
75.6 (C), 94.8 (CH), 120.5 (C), 139.3 (CH), 163.8 (C), 164.1 (C),
186.9 (CH); MS (EI) m/z 292 (M+, 100), 246 (15), 148 (13), 84
(29), 49 (27).
N,N-Diethyl-2,3,4-trimethoxy-5-iodobenzamide (7f). The reaction
was performed as described in the general procedure using N,N-
diethyl-2,3,4-trimethoxybenzamide (6f) (68 mg, 0.25 mmol) and NIS
(63 mg, 0.28 mmol). The reaction mixture was heated to 45 °C for 6
h. Puriﬁcation by column chromatography eluting with 20% ethyl
acetate in petroleum ether gave N,N-diethyl-2,3,4-trimethoxy-5-
iodobenzamide (7f) (85 mg, 85%) as a colorless oil: IR (neat)
2973, 1626, 1580, 1455, 1394, 1292, 1220, 1070, 999 cm−1; 1H NMR
(400 MHz, CDCl3) δ 1.07 (t, J 7.2 Hz, 3H), 1.24 (t, J 7.2 Hz, 3H),
3.17 (q, J 7.2 Hz, 2H), 3.43 (br s, 1H), 3.66 (br s, 1H), 3.88 (s, 3H),
3.89 (s, 3H), 3.91 (s, 3H), 7.33 (s, 1H); 13C NMR (101 MHz, CDCl3)
δ 12.8 (CH3), 14.0 (CH3), 39.0 (CH2), 43.1 (CH2), 60.9 (CH3), 61.1
(CH3), 61.7 (CH3), 85.6 (C), 129.8 (C), 130.3 (CH), 146.6 (C),
150.6 (C), 154.1 (C), 166.6 (C); MS (EI) m/z 393 (M+, 56), 321
(100), 266 (10), 195 (5), 105 (8), 73 (7); HRMS (EI) calcd for
C14H20INO4 (M
+), 393.0437, found 393.0435.
4-Iodoaniline (7g).36 The reaction was performed as described in
the general procedure using aniline (6g) (45 μL, 0.49 mmol) and NIS
(110 mg, 0.49 mmol). The reaction mixture was stirred at room
temperature for 1.5 h. Puriﬁcation by column chromatography eluting
with 10% ethyl acetate in petroleum ether gave 4-iodoaniline (7g) (88
mg, 82%) as a light brown solid: mp 53−55 °C (lit.36 mp 55−56.5
°C); 1H NMR (400 MHz, CDCl3) δ 3.67 (s, 2H), 6.44−6.49 (m, 2H),
7.38−7.43 (m, 2H); 13C NMR (101 MHz, CDCl3) δ 79.4 (C), 117.3
(2 × CH), 137.9 (2 × CH), 146.0 (C); MS (EI) m/z 219 (M+, 100),
191 (3), 127 (12), 92 (43), 65 (31).
2-Amino-5-iodoacetophenone (7h).37 The reaction was per-
formed as described in the general procedure using 2-amino-
acetophenone (6h) (59 μL, 0.48 mmol) and NIS (110 mg, 0.49
mmol). The reaction mixture was heated to 36 °C for 1.4 h.
Recrystallization from dichloromethane gave 2-amino-5-iodoacetophe-
none (7h) (112 mg, 89%) as a light brown solid: mp 95−97 °C (lit.37
mp 98.5−99 °C); 1H NMR (400 MHz, CDCl3) δ 2.54 (s, 3H), 6.31
(br s, 2H), 6.45 (d, J 8.7 Hz, 1H), 7.46 (dd, J 8.7, 2.1 Hz, 1H), 7.96 (d,
J 2.1 Hz, 1H); 13C NMR (101 MHz, CDCl3) δ 27.8 (CH3), 75.2 (C),
119.4 (CH), 120.4 (C), 140.3 (CH), 142.4 (CH), 149.6 (C), 199.6
(C); MS (EI) m/z 261 (M+, 100), 246 (52), 218 (20), 91 (18), 84
(18).
2-Amino-3-iodo-5-chlorobenzophenone (7i). The reaction was
performed as described in the general procedure using 2-amino-5-
chlorobenzophenone (6i) (109 mg, 0.47 mmol) and NIS (115 mg,
0.51 mmol). The reaction mixture was heated to 40 °C for 3 h.
Puriﬁcation by column chromatography eluting with 10% ethyl acetate
in petroleum ether gave 2-amino-3-iodo-5-chlorobenzophenone (7i)
(146 mg, 87%) as a bright yellow solid: mp 88−90 °C; IR (neat) 3396,
3289, 1634, 1596, 1564, 1518, 1226, 952, 880 cm−1; 1H NMR (500
MHz, CDCl3) δ 6.66 (br s, 2H), 7.44 (d, J 2.4 Hz, 1H), 7.46−7.51 (m,
2H), 7.55−7.64 (m, 3H), 7.81 (d, J 2.4 Hz, 1H); 13C NMR (126 MHz,
CDCl3) δ 86.7 (C), 118.4 (C), 120.2 (C), 128.4 (2 × CH), 129.2 (2 ×
CH), 131.9 (CH), 133.8 (CH), 138.7 (C), 143.0 (CH), 148.7 (C),
197.3 (C); MS (EI) m/z 357 (M+, 100), 280 (12), 229 (13), 125 (14),
105 (21), 77 (23); HRMS (EI) calcd for C13H9
35ClINO (M+)
356.9417, found 356.9419.
2-Iodo-4-nitroaniline (7j).38 The reaction was performed as
described in the general procedure using 4-nitroaniline (6j) (71 mg,
0.51 mmol) and NIS (110 mg, 0.49 mmol). The reaction mixture was
heated to 40 °C for 1.5 h. Recrystallization from ethyl acetate and
petroleum ether gave 2-iodo-4-nitroaniline (7j) (124 mg, 99%) as a
bright yellow solid: mp 99−100 °C (lit.38 mp 103−104 °C); 1H NMR
(400 MHz, CDCl3) δ 4.83 (br s, 2H), 6.70 (d, J 9.0 Hz, 1H), 8.06 (dd,
J 9.0, 2.5 Hz, 1H), 8.57 (d, J 2.5 Hz, 1H); 13C NMR (126 MHz,
CDCl3) δ 80.5 (C), 112.3 (CH), 125.7 (CH), 135.5 (CH), 139.3 (C),
152.3 (C); MS (EI) m/z 264 (M+, 100), 234 (38), 218 (11), 127 (5),
91 (31).
3-Iodo-4-aminoacetophenone (7k).39 The reaction was performed
as described in the general procedure using 4-aminoacetophenone
(6k) (66 mg, 0.48 mmol) and NIS (110 mg, 0.49 mmol). The reaction
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mixture was stirred at room temperature for 3 h. Puriﬁcation by
column chromatography eluting with 20% ethyl acetate in petroleum
ether gave 3-iodo-4-aminoacetophenone (7k) (124 mg, 98%) as a
yellow oil. The data were consistent with the literature:39 1H NMR
(500 MHz, CDCl3) δ 2.49 (s, 3H), 4.62 (br s, 2H), 6.71 (d, J 8.4 Hz,
1H), 7.76 (dd, J 8.4, 2.0 Hz, 1H), 8.27 (d, J 2.0 Hz, 1H); 13C NMR
(126 MHz, CDCl3) δ 26.0 (CH3), 82.6 (C), 113.1 (CH), 129.3 (C),
130.3 (CH), 140.3 (CH), 150.9 (C), 195.1 (C); MS (CI) m/z 262
(MH+, 100), 136 (48), 85 (10), 69 (18).
N-(4-Iodophenyl)acetamide (7l).13c The reaction was performed as
described in the general procedure using N-phenylacetamide (6l) (59
mg, 0.44 mmol) and NIS (110 mg, 0.49 mmol). The reaction mixture
was heated to 40 °C for 2 h. Recrystallization from ethyl acetate and
petroleum ether gave N-(4-iodophenyl)acetamide (7l) (104 mg, 89%)
as a white solid: mp 174−176 °C (lit.13c mp 178−180 °C); 1H NMR
(400 MHz, CDCl3) δ 2.17 (s, 3H), 7.12 (br s, 1H), 7.29 (d, J 8.7 Hz,
2H), 7.62 (d, J 8.7 Hz, 2H); 13C NMR (101 MHz, CDCl3) δ 24.7
(CH3), 87.4 (C), 121.6 (2 × CH), 137.6 (C), 137.9 (2 × CH), 168.2
(C); MS (EI) m/z 261 (M+, 100), 219 (93), 92 (26).
N-(2-Chloro-4-iodophenyl)acetamide (7m).40 The reaction was
performed as described in the general procedure using N-(2-
chlorophenyl)acetamide (6m) (73 mg, 0.43 mmol) and NIS (110
mg, 0.49 mmol). The reaction mixture was heated to 40 °C for 7 h.
Recrystallization from ethyl acetate and petroleum ether gave N-(2-
chloro-4-iodophenyl)acetamide (7m) (110 mg, 87%) as a white
powder: mp 138−139 °C (lit.40 mp 144 °C); 1H NMR (500 MHz,
CDCl3) δ 2.24 (s, 3H), 7.52−7.59 (m, 2H), 7.69 (d, J 2.0 Hz, 1H),
8.17 (d, J 8.7 Hz, 1H); 13C NMR (126 MHz, CDCl3) δ 24.9 (CH3),
86.2 (C), 122.8 (CH), 123.1 (C), 134.5 (C), 136.8 (CH), 137.0
(CH), 168.2 (C); MS (EI) m/z 295 (M+, 48), 253 (100), 224 (6), 126
(15), 90 (15).
4-Iodo-1-methoxynaphthalene (7n).41 The reaction was per-
formed as described in the general procedure using 1-methoxynaph-
thalene (6n) (69 μL, 0.48 mmol) and NIS (110 mg, 0.49 mmol). The
reaction mixture was heated to 36 °C for 1 h. Puriﬁcation by column
chromatography eluting with 2.5% ethyl acetate in petroleum ether
gave 4-iodo-1-methoxynaphthalene (7n) (114 mg, 83%) as a colorless
oil. The data were consistent with the literature:41 1H NMR (500
MHz, CDCl3) δ 3.99 (s, 3H), 6.60 (d, J 8.1 Hz, 1H), 7.51 (ddd, J 8.3,
6.8, 1.1 Hz, 1H), 7.58 (ddd, J 8.4, 6.8, 1.3 Hz, 1H), 7.95 (d, J 8.1 Hz,
1H), 8.02 (ddd, J 8.4, 1.1, 0.6, 1H), 8.23 (ddd, J 8.3, 1.3, 0.6 Hz, 1H);
13C NMR (101 MHz, CDCl3) δ 55.7 (CH3), 88.2 (C), 105.6 (CH),
122.5 (CH), 126.0 (CH), 126.7 (C), 128.2 (CH), 131.8 (CH), 134.7
(C), 136.9 (CH), 156.3 (C); MS (EI) m/z 284 (M+, 100), 269 (35),
241 (31), 114 (30).
1-Iodo-2-methoxynaphthalene (7o).19 The reaction was per-
formed as described in the general procedure using 2-methoxynaph-
thalene (6o) (76 mg, 0.48 mmol) and NIS (110 mg, 0.49 mmol). The
reaction mixture was heated to 36 °C for 1 h. Puriﬁcation by column
chromatography eluting with 5% ethyl acetate in petroleum ether gave
1-iodo-2-methoxynaphthalene (7o) (132 mg, 97%) as an oﬀ-white
solid: mp 84−86 °C (lit.19 mp 86−87 °C); 1H NMR (400 MHz,
CDCl3) δ 4.03 (s, 3H), 7.22 (d, J 8.9 Hz, 1H), 7.38 (ddd, J 8.1, 6.9, 1.2
Hz, 1H), 7.54 (ddd, J 8.6, 6.9, 1.2 Hz, 1H), 7.74 (ddd, J 8.1, 1.2, 0.6
Hz, 1H), 7.83 (d, J 8.9 Hz, 1H), 8.14 (ddd, J 8.6, 1.2, 0.6 Hz, 1H); 13C
NMR (126 MHz, CDCl3) δ 57.3 (CH3), 87.7 (C), 112.9 (CH), 124.4
(CH), 128.1 (CH), 128.2 (CH), 129.9 (C), 130.4 (CH), 131.2 (CH),
135.6 (C), 156.6 (C); MS (EI) m/z 284 (M+, 52), 241 (21), 142 (20),
114 (23), 84 (24), 44 (100).
5-Iodo-2,3-dihydrobenzofuran (7p).42 The reaction was per-
formed as described in the general procedure using 2,3-dihydrobenzo-
furan (6p) (54 μL, 0.48 mmol) and NIS (110 mg, 0.49 mmol). The
reaction mixture was heated to 36 °C for 1 h. Puriﬁcation by column
chromatography eluting with 2.5% ethyl acetate in petroleum ether
gave 5-iodo-2,3-dihydrobenzofuran (7p) (117 mg, 99%) as a white
solid: mp 61−63 °C (lit.42 mp 64−65 °C); 1H NMR (400 MHz,
CDCl3) δ 3.20 (br t, J 8.7 Hz, 2H), 4.56 (t, J 8.7 Hz, 2H), 6.57 (d, J
8.4 Hz, 1H), 7.38 (ddt, J 8.4, 1.9, 0.7 Hz, 1H), 7.47 (dt, J 1.9, 1.1 Hz,
1H); 13C NMR (126 MHz, CDCl3) δ 29.5 (CH2), 71.4 (CH2), 81.6
(C), 111.7 (CH), 130.1 (C), 133.7 (CH), 136.7 (CH), 160.0 (C); MS
(EI) m/z 246 (M+, 89), 232 (10), 117 (20), 91 (41), 84 (39), 44
(100).
Methyl 4-Iodo-1H-pyrrole-2-carboxylate (7q).43 The reaction was
performed as described in the general procedure using methyl 1H-
pyrrole-2-carboxylate (6q) (61 mg, 0.48 mmol) and NIS (110 mg,
0.49 mmol). The reaction mixture was stirred at room temperature for
0.5 h. Puriﬁcation by column chromatography eluting with 15% ethyl
acetate in petroleum ether gave methyl 4-iodo-1H-pyrrole-2-
carboxylate (7q) (87 mg, 72%) as a white solid: mp 87−90 °C
(lit.43 mp 87−89 °C); 1H NMR (400 MHz, CDCl3) δ 3.86 (s, 3H),
6.98 (dd, J 2.7, 1.5 Hz, 1H), 7.00 (dd, J 2.7, 1.5 Hz, 1H), 9.10 (br s,
1H); 13C NMR (126 MHz, CDCl3) δ 51.8 (CH3), 61.7 (C), 121.7
(CH), 124.4 (C), 127.6 (CH), 160.5 (C); MS (EI) m/z 251 (M+,
100), 219 (70), 192 (11), 124 (5), 93 (6), 65 (8), 44 (10).
4-Iodophenol (10a).44 The reaction was performed as described in
the highly reactive substrate procedure using phenol (9a) (46 mg, 0.49
mmol) and NIS (113 mg, 0.50 mmol) at 0 °C. After 15 min, the
reaction mixture was slowly heated to 36 °C for 4 h. Puriﬁcation by
column chromatography, eluting with 10% ethyl acetate in petroleum
ether gave 4-iodophenol (10a) (93 mg, 86%) as a waxy solid. The data
were consistent with the literature:44 1H NMR (400 MHz, CDCl3) δ
4.68 (s, 1H), 6.63 (d, J 8.8 Hz, 2H), 7.52 (d, J 8.8 Hz, 2H); 13C NMR
(126 MHz, CDCl3) δ 82.7 (C), 117.8 (2 × CH), 138.5 (2 × CH),
155.3 (C); MS (EI) m/z 220 (M+, 100), 191 (3), 127 (6), 93 (37), 65
(20).
2-Hydroxy-5-iodoacetophenone (10b).45 The reaction was
performed as described in the general procedure using 2-
hydroxyacetophenone (9b) (56 μL, 0.46 mmol) and NIS (109 mg,
0.49 mmol). The reaction mixture was heated to 40 °C for 6.7 h.
Recrystallization from ethyl acetate and petroleum ether gave 2-
hydroxy-5-iodoacetophenone (10b) (112 mg, 93%) as a light yellow
solid: mp 84−86 °C (lit.45 mp 90 °C); δH (400 MHz, CDCl3) δ 2.62
(s, 3H), 6.78 (d, J 8.8 Hz, 1H), 7.71 (dd, J 8.8, 2.2 Hz, 1H), 8.01 (d, J
2.2 Hz, 1H), 12.19 (s, 1H); 13C NMR (126 MHz, CDCl3) δ 26.8
(CH3), 79.7 (C), 120.9 (CH), 121.8 (C), 139.1 (CH), 144.8 (CH),
162.0 (C), 203.5 (C); MS (EI) m/z 262 (M+, 100), 247 (72), 219
(19), 120 (10), 92 (14), 63 (9).
2,6-Dihydroxy-3-iodoacetophenone (10c). The reaction was
performed as described in the highly reactive substrate procedure
using 2,6-dihydroxyacetophenone (9c) (75 mg, 0.49 mmol) and NIS
(115 mg, 0.51 mmol) at 0 °C for 10 min. The reaction mixture was
warmed to room temperature and stirred for 1 h. Recrystallization
from ethyl acetate and petroleum ether gave 2,6-dihydroxy-3-
iodoacetophenone (10c) (100 mg, 74%) as a yellow solid: mp 143−
146 °C (decomposition); IR (neat) 3254, 2922, 1607, 1575, 1419,
1409, 1362, 1339, 1263, 1206, 1132, 1046, 803 cm−1; 1H NMR (400
MHz, CDCl3) δ 2.76 (s, 3H), 6.38 (d, J 8.8 Hz, 1H), 7.48 (br s, 1H),
7.64 (d, J 8.8 Hz, 1H), 11.82 (br s, 1H); 13C NMR (126 MHz, CDCl3)
δ 33.4 (CH3), 74.1 (C), 110.3 (C), 112.1 (CH), 143.7 (CH), 157.2
(C), 163.8 (C), 204.8 (C); MS (EI) m/z 278 (M+, 54), 263 (56), 247
(11), 137 (22), 108 (10), 44 (100); HRMS (EI) calcd for C8H7IO3
(M+) 277.9440, found 277.9439.
2-Hydroxy-3-iodo-6-methoxybenzaldehyde (10d). The reaction
was prepared as described in the highly reactive substrate procedure
using 2-hydroxy-6-methoxybenzaldehyde (9d) (72 mg, 0.47 mmol)
and NIS (109 mg, 0.49 mmol) at 0 °C. After 10 min, the reaction
mixture was warmed to room temperature and stirred for 1 h.
Recrystallization from ethyl acetate and petroleum ether gave 2-
hydroxy-3-iodo-6-methoxybenzaldehyde (10d) (127 mg, 97%) as a
yellow solid: mp 123−125 °C; IR (neat) 2942, 2900, 1634, 1597,
1384, 1283, 1246, 1089, 780 cm−1; 1H NMR (500 MHz, CDCl3) δ
3.91 (s, 3H), 6.29 (d, J 8.8 Hz, 1H), 7.85 (d, J 8.8 Hz, 1H), 10.21 (s,
1H), 12.83 (s, 1H); 13C NMR (126 MHz, CDCl3) δ 56.1 (CH3), 74.2
(C), 103.7 (CH), 111.0 (C), 146.9 (CH), 162.1 (C), 162.9 (C), 193.7
(C); MS (EI) m/z 278 (M+, 71), 260 (10), 218 (7), 133 (9), 105 (8),
84 (96), 49 (100); HRMS (EI) calcd for C8H7IO3 (M
+) 277.9440,
found 277.9438.
2,4-Dimethoxy-5-iodo-6-hydroxybenzaldehyde (10e). The reac-
tion was performed as described in the general procedure using 2,4-
dimethoxy-6-hydroxybenzaldehyde (9e) (84 mg, 0.46 mmol) and NIS
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(110 mg, 0.49 mmol). The reaction mixture was heated to 36 °C for 2
h. Recrystallization from ethyl acetate and petroleum ether gave 2,4-
dimethoxy-5-iodo-6-hydroxybenzaldehyde (10e) (128 mg, 90%) as an
oﬀ-white solid: mp 205−208 °C (decomposition); IR (neat) 3022,
2943, 1635, 1603, 1462, 1449, 1293, 1233, 1210, 1177, 1127, 1080,
977, 783 cm−1; 1H NMR (400 MHz, CDCl3) δ 3.94 (s, 3H), 3.98 (s,
3H), 6.00 (s, 1H), 10.00 (s, 1H), 13.22 (s, 1H); 13C NMR (101 MHz,
CDCl3) δ 56.0 (CH3), 56.7 (CH3), 65.7 (C), 86.7 (CH), 106.4 (C),
164.0 (C), 164.8 (C), 166.0 (C), 191.5 (C); MS (EI) 308 (M+, 100),
277 (13), 246 (11), 163 (20), 91 (8), 69 (7); HRMS (EI) calcd for
C9H9IO4 (M
+) 307.9546, found 307.9547.
N-[2′-(1″-Piperidinyl)ethyl]-4-methoxybenzamide (11).7a 1-Ethyl-
3-(3-(dimethylamino)propyl)carbodiimide hydrochloride (1.44 g, 7.5
mmol), hydroxybenzotriazole (1.08 g, 8.0 mmol), and 4-methox-
ybenzoic acid (761 mg, 5.0 mmol) were dissolved in dichloromethane
(20 mL). N,N-Diisopropylethylamine (2.8 mL, 16 mmol) was added,
and the mixture was stirred at room temperature for 1 h. 2-(1′-
Piperidyl)ethylamine (1.00 mL, 5.0 mmol) was added and the reaction
mixture was stirred at room temperature for 24 h. The mixture was
diluted with dichloromethane (100 mL) and extracted with 1 M
hydrochloric acid (100 mL). The aqueous layer was neutralized with 1
M sodium hydroxide (∼120 mL) and extracted with dichloromethane
(3 × 100 mL). The organic layer was dried over MgSO4, ﬁltered, and
concentrated under reduced pressure to give a yellow oil. Puriﬁcation
by column chromatography eluting with 5−10% methanol in
dichloromethane gave N-[2′-(1″-piperidinyl)ethyl]-4-methoxybenza-
mide (11) (916 mg, 70%) as a colorless solid. The data were
consistent with the literature:7a mp 71−73 °C; 1H NMR (500 MHz,
CDCl3) δ 1.42−1.51 (m, 2H), 1.57−1.66 (m, 4H), 2.39−2.49 (br m,
4H), 2.55 (t, J 6.1 Hz, 2H), 3.51 (td, J 6.1, 4.7 Hz, 2H), 3.85 (s, 3H),
6.86 (br s, 1H), 6.91−6.97 (m, 2H), 7.73−7.78 (m, 2H); 13C NMR
(126 MHz, CDCl3) δ 24.4 (CH2), 26.1 (2 × CH2), 36.4 (CH2), 54.2
(2 × CH2), 55.4 (CH3), 57.0 (CH2), 113.7 (2 × CH), 127.1 (C),
128.7 (2 × CH), 162.0 (C), 166.8 (C); MS (ESI) m/z 263 (MH+, 75),
178 (100).
N-[2′-(1″-Piperidinyl)ethyl]-3-iodo-4-methoxybenzamide (3).7a
N-[2′-(1″-Piperidinyl)ethyl]-4-methoxybenzamide (11) (50 mg, 0.19
mmol) was suspended in acetonitrile (3 mL), and then tetraﬂuor-
oboric acid (25 μL, 0.19 mmol, 48 wt % in water) was added at room
temperature. The resulting solution was concentrated to a yellowish
gum under reduced pressure. The reaction was then performed as
described in the general procedure using the HBF4 salt and NIS (56
mg, 0.25 mmol). The reaction mixture was heated to 40 °C for 2.3 h.
Puriﬁcation by column chromatography eluting with 5% to 10%
methanol in dichloromethane gave N-[2′-(1″-piperidinyl)ethyl]-3-
iodo-4-methoxybenzamide (3) (70 mg, 94%) as a viscous colorless oil.
The data were consistent with the literature:7a 1H NMR (500 MHz,
CDCl3) δ 1.42−1.51 (m, 2H), 1.56−1.64 (m, 4H), 2.35−2.48 (br m,
4H), 2.54 (t, J 6.1 Hz, 2H), 3.49 (td, J 6.1, 4.7 Hz, 2H), 3.93 (s, 3H),
6.80 (br s, 1H), 6.84 (d, J 8.6 Hz, 1H), 7.77 (dd, J 8.6, 2.2 Hz, 1H),
8.21 (d, J 2.2 Hz, 1H); 13C NMR (126 MHz, CDCl3) δ 24.4 (CH2),
26.1 (2 × CH2), 36.5 (CH2), 54.3 (2 × CH2), 56.5 (CH3), 57.0
(CH2), 85.7 (C), 110.1 (CH), 128.7 (CH), 128.9 (C), 138.5 (CH),
160.3 (C), 165.5 (C); MS (ESI) m/z 389 (MH+, 100), 304 (43).
(2′S)-2-Hydroxy-6-methoxy-N-[(1′-ethyl-2′-pyrrolidinyl)methyl]-
benzamide (12).8a 1-Ethyl-3-(3-(dimethylamino)propyl)carbodiimide
hydrochloride (494 mg, 2.57 mmol), hydroxybenzotriazole (371 mg,
2.75 mmol), and 2-hydroxy-6-methoxybenzoic acid (289 mg, 1.72
mmol) were dissolved in dichloromethane (5 mL). N,N-Diisopropy-
lethylamine (747 μL, 4.29 mmol) was added, and the mixture was
stirred at room temperature for 0.1 h. (S)-(−)-1-Ethyl-2-amino-
methylpyrrolidine (239 μL, 1.72 mmol) was added, and the reaction
mixture was stirred at room temperature for 24 h. The mixture was
diluted with dichloromethane (50 mL), washed with 1 M sodium
hydroxide (50 mL), dried (MgSO4), ﬁltered, and concentrated under
reduced pressure. Puriﬁcation by column chromatography eluting with
0% to 3.5% methanol in dichloromethane gave (2′S)-2-hydroxy-6-
methoxy-N-[(1′-ethyl-2′-pyrrolidinyl)methyl]benzamide (12) (363
mg, 76%) as a colorless oil. The data were consistent with the
literature:8a [α]D
23 −78.0 (c 2.0, acetone); 1H NMR (500 MHz,
CDCl3) δ 1.13 (t, J 7.2 Hz, 3H), 1.63 (dt, J 12.6, 5.9 Hz, 1H), 1.67−
1.76 (m, 2H), 1.91 (dq, J 12.6, 8.5 Hz, 1H), 2.17−2.29 (m, 2H), 2.65
(m, 1H), 2.85 (dq, J 13.5, 7.2 Hz, 1H), 3.17−3.33 (m, 2H), 3.70 (ddd,
J 13.8, 7.2, 2.5 Hz, 1H), 3.92 (s, 3H), 6.39 (dd, J 8.3, 1.0 Hz, 1H), 6.62
(dd, J 8.4, 1.0 Hz, 1H), 7.26 (dd, J 8.4, 8.3 Hz, 1H), 8.92 (br s, 1H),
14.14 (s, 1H); 13C NMR (101 MHz, CDCl3) δ 14.2 (CH3), 23.0
(CH2), 28.5 (CH2), 40.7 (CH2), 47.9 (CH2), 53.6 (CH2), 55.9 (CH3),
61.9 (CH), 100.8 (CH), 104.2 (C), 111.6 (CH), 133.0 (CH), 158.8
(C), 164.5 (C), 170.3 (C); MS (EI) m/z 278 (M+, 4), 151 (41), 136
(10), 98 (100), 70 (22).
(2′S)-2-Hydroxy-3-iodo-6-methoxy-N-[(1′-ethyl-2′-pyrrolidinyl)-
methyl]benzamide (4).8a (2′S)-2-Hydroxy-6-methoxy-N-[(1′-ethyl-
2′-pyrrolidinyl)methyl]benzamide (12) (69 mg, 0.25 mmol) was
suspended in ethanol (3 mL), and then tetraﬂuoroboric acid (32.4 μL,
0.25 mmol, 48 wt % in water) was added at room temperature. After
0.5 h, the resulting solution was concentrated to a yellowish gum
under reduced pressure. The reaction was then performed as described
in the general procedure using the prepared salt and NIS (57 mg, 0.25
mmol). The reaction mixture was stirred at room temperature for 0.8
h. Puriﬁcation by column chromatography eluting with 2−5%
methanol in dichloromethane gave (2′S)-2-hydroxy-3-iodo-6-me-
thoxy-N-[(1′-ethyl-2′-pyrrolidinyl)methyl]benzamide (4) (71 mg,
71%) as a colorless viscous oil. The data were consistent with the
literature:8a [α]D
24 −47.3 (c 1.0 in acetone); 1H NMR (500 MHz,
CD3OD) δ 1.19 (t, J 7.3 Hz, 3H), 1.62−1.72 (m, 1H), 1.74−1.88 (m,
2H), 2.01 (dq, J 12.7, 8.3 Hz, 1H), 2.35−2.50 (m, 2H), 2.83−2.91 (m,
1H), 3.01 (dq, J 12.2, 7.3 Hz, 1H), 3.26−3.33 (m, 1H), 3.41 (dd, J
13.8, 5.6 Hz, 1H), 3.63 (dd, J 13.8, 4.0 Hz, 1H), 3.95 (s, 3H), 6.43 (d,
J 8.8 Hz, 1H), 7.74 (d, J 8.8 Hz, 1H); 13C NMR (126 MHz, CD3OD)
δ 12.3 (CH3), 22.2 (CH2), 28.0 (CH2), 40.9 (CH2), 48.5 (CH2), 53.4
(CH2), 55.8 (CH3), 63.2 (CH), 75.7 (C), 103.5 (CH), 103.9 (C),
142.2 (CH), 159.4 (C), 162.1 (C), 169.8 (C); MS (EI) m/z 404 (M+,
3), 277 (22), 261 (9), 234 (5), 149 (8), 98 (100), 70 (14).
3,4-Diﬂuoro-2-(2′-ﬂuorophenylamino)benzoic Acid.46 2,3,4-Tri-
ﬂuorobenzoic acid (250 mg, 1.42 mmol) was dissolved in THF (10
mL) under an atmosphere of argon. 2-Fluoroaniline (0.28 mL, 2.84
mmol) was added, and the mixture was cooled to −78 °C. Lithium
bis(trimethylsilyl)amide (1 M in THF, 4.4 mL, 4.26 mmol) was slowly
added over 0.1 h. The reaction mixture was warmed to room
temperature and stirred for 72 h. The reaction was quenched with
water (10 mL) and acidiﬁed to pH 2 with dilute hydrochloric acid.
The mixture was extracted with ethyl acetate (3 × 80 mL), dried
(Na2SO4), ﬁltered, and concentrated under reduced pressure. The
resulting brown residue was recrystallized from ethyl acetate and
hexane to give 3,4-diﬂuoro-2-(2′-ﬂuorophenylamino)benzoic acid
(232 mg, 61%) as a white solid: mp 174−175 °C (lit.46 mp 170−
172 °C); 1H NMR (400 MHz, CDCl3) δ 6.76 (td, J 9.2, 6.8 Hz, 1H),
6.98−7.16 (m, 4H), 7.89 (ddd, J 9.2, 5.8, 2.1 Hz, 1H), 8.91 (s, 1H);
13C NMR (126 MHz, CD3OD) δ 108.6 (d, J 18.4 Hz, CH), 115.9 (C),
116.1 (d, J 19.4 Hz, CH), 121.9 (d, J 5.8 Hz, CH), 124.5 (d, J 7.5 Hz,
CH), 125.1 (d, J 3.7 Hz, CH), 129.1 (dd, J 9.6, 4.0 Hz, CH), 131.2 (d,
J 10.0 Hz, C), 138.0 (d, J 7.6 Hz, C), 142.1 (dd, J 247.9, 14.9 Hz, C),
155.4 (dd, J 252.3, 11.2 Hz, C), 156.1 (d, J 243.3 Hz, C), 170.3 (C);
19F NMR (377 MHz, CDCl3) δ −144.2 (d, J 18.6 Hz, 1F), −127.4 (s,
1F), −126.3 (d, J 18.6 Hz, 1F); MS (EI) m/z 267 (M+, 51), 249 (100),
221 (23), 201 (16), 84 (64), 49 (44).
Methyl 3,4-Diﬂuoro-2-(2′-ﬂuorophenylamino)benzoate (13). 3,4-
Diﬂuoro-2-(2′-ﬂuorophenylamino)benzoic acid (160 mg, 0.60 mmol)
was dissolved in toluene (6 mL) under an atmosphere of argon.
Thionyl chloride (2.6 mL) was added, and the reaction mixture was
heated to 80 °C for 5 h. The reaction mixture was cooled to room
temperature and concentrated under reduced pressure. The residue
was dissolved in toluene (4 mL), and a mixture of methanol (6 mL)
and triethylamine (1.5 mL) was added. The mixture was stirred
overnight at room temperature. The volatiles were removed under
reduced pressure. The resulting residue was dissolved in dichloro-
methane (40 mL) and washed with a saturated solution of sodium
hydrogen carbonate (40 mL). The aqueous layer was extracted with
dichloromethane (2 × 50 mL). The organic phases were combined,
dried (MgSO4), ﬁltered, and concentrated under reduced pressure.
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The residue was puriﬁed by ﬁltration through a plug of silica eluting
with 4% ethyl acetate in hexane to give methyl 3,4-diﬂuoro-2-(2′-
ﬂuorophenylamino)benzoate (13) (150 mg, 89%) as white solid: mp
65−67 °C; IR (neat) 3281, 2955, 1692, 1611, 1501, 1437, 1258, 1192,
1134, 1103, 1053, 1003, 746 cm−1; 1H NMR (400 MHz, CDCl3) δ
3.91 (s, 3H), 6.73 (td, J 9.1, 6.9 Hz, 1H), 6.93−7.14 (m, 4H), 7.79
(ddd, J 9.1, 5.9, 2.2 Hz, 1H), 9.08 (s, 1H); 13C NMR (101 MHz,
CDCl3) δ 52.4 (CH3), 107.6 (d, J 18.3 Hz, CH), 113.7 (t, J 2.7 Hz, C),
115.4 (d, J 19.3 Hz, CH), 120.9 (dd, J 6.0, 1.8 Hz, CH), 123.5 (d, J 7.4
Hz, CH), 123.8 (d, J 3.8 Hz, CH), 127.3 (dd, J 9.5, 4.2 Hz, CH), 129.7
(dd, J 11.2, 2.5 Hz, C), 136.8 (dd, J 7.7, 3.4 Hz, C), 141.9 (dd, J 249.7,
14.7 Hz, C), 154.3 (dd, J 254.6, 11.4 Hz, C), 154.8 (d, J 244.8 Hz, C),
167.5 (d, J 2.7 Hz, C); 19F NMR (377 MHz, CDCl3) δ −143.7 (d, J
18.7 Hz, 1F), −128.3 (d, J 18.7 Hz, 1F), −128.1 (s, 1F); HRMS (ESI)
calcd for C14H10F3NNaO2 (MNa
+), 304.0556, found 304.0552.
Methyl 3,4-Diﬂuoro-2-(2′-ﬂuoro-4′-iodophenylamino)benzoate
(14).46 The reaction was performed as described in the general
procedure using methyl 3,4-diﬂuoro-2-(2′-ﬂuorophenylamino)-
benzoate (13) (47 mg, 0.17 mmol) and NIS (38 mg, 0.17 mmol).
The reaction mixture was stirred at room temperature for 1 h. The
residue was puriﬁed by ﬁltration through a plug of silica eluting with
4% ethyl acetate in hexane to give methyl 3,4-diﬂuoro-2-(2′-ﬂuoro-4′-
iodophenylamino)benzoate (14) (64 mg, 94%) as an oﬀ-white solid.
The data were consistent with the literature:46 mp 109−111 °C; 1H
NMR (400 MHz, CDCl3) δ 3.91 (s, 3H), 6.68 (td, J 8.5, 5.8 Hz, 1H),
6.77 (td, J 9.1, 7.0 Hz, 1H), 7.35 (dt, J 8.5, 1.5 Hz, 1H), 7.42 (dd, J
10.2, 2.0 Hz, 1H), 7.80 (ddd, J 9.1, 5.8, 2.0 Hz, 1H), 9.05 (br s, 1H);
13C NMR (101 MHz, CDCl3) δ 52.5 (s, CH3), 83.6 (d, J 7.6 Hz, C),
108.3 (d, J 18.3 Hz, CH), 114.1 (t, J 2.6 Hz, C), 121.8 (dd, J 6.5, 2.1
Hz, CH), 124.4 (d, J 21.7 Hz, CH), 127.4 (dd, J 9.4, 4.1 Hz, CH),
130.0 (dd, J 10.1, 2.5 Hz, C), 132.9 (d, J 3.9 Hz, CH), 135.9 (dd, J 7.9,
3.7 Hz, C), 142.0 (dd, J 250.2, 14.8 Hz, C), 154.1 (d, J 250.4 Hz, C),
154.2 (dd, J 255.3, 11.4 Hz, C), 167.4 (d, J 2.7 Hz, C); 19F NMR (377
MHz, CDCl3) δ −142.9 (d, J 18.7 Hz, 1F), −127.8 (d, J 18.7 Hz, 1F),
−125.8 (s, 1F); MS (ESI) m/z 430 (MNa+, 100), 381 (54), 353 (19),
317 (99), 257 (22), 117 (53).
[125I]-4-Iodo-1-methoxynaphthalene ([125I]-7n). To a vial was
added N-chlorosuccinimide (0.44 mg, 3.3 μmol) in acetonitrile (0.1
mL) and [125I]-sodium iodide in acetonitrile (5 μL, 5.3 MBq). The
mixture was stirred at ambient temperature for 0.75 h. Silver triﬂimide
(0.72 mg, 1.86 μmol) in dichloromethane (0.3 mL) and 1-
methoxynaphthalene (6n) (0.45 μL, 3.1 μmol) in dichloromethane
(0.3 mL) were then added via syringe, and the reaction mixture was
stirred at 36 °C for 1.1 h. A 50% aqueous acetonitrile solution (0.8
mL) was added, and the reaction volume was concentrated by blowing
argon over the solution. The mixture was diluted with aqueous
acetonitrile solution and passed through a 0.22 μm ﬁlter. The ﬁltrate
was analyzed by analytical radio-HPLC which showed incorporation of
radioiodide to obtain [125I]-4-iodo-1-methoxynaphthalene ([125I]-7n)
in 61% radiochemical yield.
[125I]-2-Hydroxy-3-iodo-6-methoxybenzaldehyde ([125I]-10d). To
a vial was added N-chlorosuccinimide (0.43 mg, 3.2 μmol) in
acetonitrile (0.1 mL) and [125I]-sodium iodide in acetonitrile (4 μL,
2.7 MBq). The mixture was stirred at ambient temperature for 0.75 h.
Silver triﬂimide (0.36 mg, 0.93 μmol) in dichloromethane (0.3 mL)
and 2-hydroxy-6-methoxybenzaldehyde (9d) (0.45 mg, 3.0 μmol) in
dichloromethane (0.3 mL) were then added via syringe, and the
reaction mixture was stirred at 36 °C for 0.3 h. The reaction volume
was concentrated by blowing argon over the solution. A 50% aqueous
acetonitrile solution (0.7 mL) was added, and the mixture was passed
through a 0.22 μm ﬁlter. The ﬁltrate was analyzed by analytical radio-
HPLC which showed incorporation of radioiodide to obtain [125I]-2-
hydroxy-3-iodo-6-methoxybenzaldehyde ([125I]-10d) in 64% radio-
chemical yield.
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(24) Antoniotti, S.; Dalla, V.; Duñach, E. Angew. Chem., Int. Ed. 2010,
49, 7860.
(25) In accordance with other transition metal catalyzed halogen-
ation of arenes by N-halosuccinimides, strongly deactivated com-
pounds such as methyl benzoate or nitrobenzene showed no
conversion with the silver(I) triﬂimide process.
(26) Eﬃcient iodination of phenols 9b and 9e was achieved without
the need for initial cooling of the reaction mixture.
(27) Rice, K. D.; Aay, N.; Anand, N. K.; Blazey, C. M.; Bowles, O. J.;
Bussenius, J.; Costanzo, S.; Curtis, J. K.; Defina, S. C.; Dubenko, L.;
Engst, S.; Joshi, A. A.; Kennedy, A. R.; Kim, A. I.; Koltun, E. S.;
Lougheed, J. C.; Manalo, J.-C. L.; Martini, J.-F.; Nuss, J. M.; Peto, C. J.;
Tsang, T. H.; Yu, P.; Johnston, S. ACS Med. Chem. Lett. 2012, 3, 416.
(28) Vankar, Y. D.; Kumaravel, G. Tetrahedron Lett. 1984, 25, 233.
(29) Radioiodinated NIS can be prepared from the reaction of
radiolabeled iodide with succinimide derivatives. For example, see:
(a) Youfeng, H.; Coenen, H. H.; Petzold, G.; Stöcklin, G. J. Labelled
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